Open in app
Recursion
Recursion
Sign inGet started
Go to Recursion
About
Recursion
Drug discovery, reimagined through artificial intelligence
Note from the editor

Drug discovery, reimagined through artificial intelligence

Editors
Go to the profile of Ron Alfa
Ron Alfa
Physician-Scientist, Translational Discovery, Commercial Strategy and Chief Evangelist at Recursion: Decoding biology to radically improve lives.
Go to the profile of Christopher Gibson
Christopher Gibson
Scientist, entrepreneur, father and husband. Co-Founder and CEO, Recursion Pharma.
Go to the profile of Recursion
Recursion
Writers
Go to the profile of Ron Alfa
Ron Alfa
Physician-Scientist, Translational Discovery, Commercial Strategy and Chief Evangelist at Recursion: Decoding biology to radically improve lives.
Go to the profile of Yolanda Chong
Yolanda Chong
Vice President, Biology at Recursion Pharmaceuticals
Go to the profile of Christopher Gibson
Christopher Gibson
Scientist, entrepreneur, father and husband. Co-Founder and CEO, Recursion Pharma.
Go to the profile of Tina Larson
Tina Larson